Palonosetron percutaneous absorption patch and preparation method thereof

A technology of palonosetron and absorption accelerator, applied in the field of medicine

Active Publication Date: 2016-11-02
SHENYANG PHARMA UNIVERSITY
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the prior art, there is no relevant report on the patch of this type of palonosetron

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Palonosetron percutaneous absorption patch and preparation method thereof
  • Palonosetron percutaneous absorption patch and preparation method thereof
  • Palonosetron percutaneous absorption patch and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] 0.5 g of palonosetron hydrochloride was dissolved in 20 ml of distilled water, and an aqueous solution of sodium hydroxide was added dropwise until no white turbidity occurred. Extract with 120ml of ethyl acetate for 5 times, combine the extracts, add an appropriate amount of anhydrous sodium sulfate for dehydration, and then dry by rotary evaporation to obtain palonosetron free base.

Embodiment 2

[0029]Disperse 0.121g of palonosetron hydrochloride (equivalent to 0.108g free base) into 2.55g of the polyacrylate pressure-sensitive adhesive DT-2287 of American National Starch Co. Dry at 60°C for 15 minutes, then cover with a backing material including PVC or non-woven fabric, and die-cut to make a patch with a thickness of 30 μm.

Embodiment 3

[0031] Palonosetron free base 0.108g obtained by ethyl acetate extraction was dispersed in 2.55g polyacrylate pressure-sensitive adhesive DT-2287 of National Starch Company of the United States, fully mixed, evenly coated on the release layer, and after 60 After drying at ℃ for 15 min, it was covered with a backing material including PVC or non-woven fabric, and punched to make a patch with a thickness of 30 μm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
melting pointaaaaaaaaaa
Login to view more

Abstract

The invention belongs to the technical field of medicine, and relates to a palonosetron percutaneous absorption patch and a preparation method thereof. The patch of the invention is composed of a backing layer, a drug-loaded pressure-sensitive adhesive layer and an anti-adhesive layer; Absorption enhancer. Wherein the β-cyclodextrin inclusion complex of palonosetron free base accounts for 4.78%-20.09% of the total weight, preferably 9%-19%, the pressure-sensitive adhesive accounts for 68.80%-95.22% by weight, and the transdermal absorption accelerator Accounting for 0~11.11wt% of the total weight. In the β-cyclodextrin inclusion compound of palonosetron free base, the ratio of the palonosetron free base to the β-cyclodextrin inclusion compound is 1:1-3. The palonosetron percutaneous absorption patch provided by the present invention is selected from the β-cyclodextrin inclusion complex of palonosetron free base, which successfully achieves a drug-free absorption within 7 days compared with the drug-unincluded patch. Release slowly.

Description

Technical field: [0001] The invention belongs to the technical field of medicine, and relates to a palonosetron percutaneous absorption patch and a preparation method thereof. Background technique: [0002] In the past 30 years, the incidence of cancer in the world has been increasing at an average annual rate of 3% to 5%. Cancer may surpass cardiovascular and cerebrovascular diseases to become the number one threat to human life. According to statistics, 70% to 80% of cancer patients receiving chemotherapy and radiotherapy will experience nausea and vomiting (chemotherapy-induced nausea and vomiting, CINV). Nausea and vomiting will cause dehydration, electrolyte imbalance, aspiration pneumonia, aggravation of the patient's condition, weakness, depression, intolerable vomiting, fear or even refusal of radiotherapy and chemotherapy, and will also increase the psychological and economic burden of family members and increase the workload of nursing . Therefore, it is imminent...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/48A61K9/70A61K31/473A61P1/08A61K47/69
Inventor 方亮惠美权鹏
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap